Skip to main content
Ranexa-H-C-PSUSA-00002611-201501: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Ranexa-H-C-PSUSA-00002611-201501: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

7 Aufrufe
Herunterladen
Pharmazeutisch

Ranexa-H-C-PSUSA-00002611-201501: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Fortschrittliche pharmazeutische Formulierung für gezielte therapeutische Intervention.

Dosierung

Ranexa-H-C-PSUSA-00002611-201501: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Stärke

Ranexa-H-C-PSUSA-00002611-201501: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Packungsgröße

Ranexa-H-C-PSUSA-00002611-201501: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Form

Ranexa-H-C-PSUSA-00002611-201501: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Sicherheitsprofil

Kontraindikationen

Ranexa-H-C-PSUSA-00002611-201501: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Nebenwirkungen

Ranexa-H-C-PSUSA-00002611-201501: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Verwandte klinische Artikel

Scanne diesen QR-Code, um schnell auf diese Seite auf deinem Mobilgerät zuzugreifen.

QR Code